Cost minimization analysis of a hexavalent vaccine in Argentina

CONCLUSIONS: The switch to an alternative scheme with the hexavalent vaccine in Argentina would result in marginally higher vaccine costs, which are mostly offset by the lower costs associated with improved logistics, fewer separate vaccines, and a reduction in adverse events.PMID:37803345 | DOI:10.1186/s12913-023-10038-0

Source: Cell Research - October 6, 2023 Category: Cytology Authors: Ignacio Olivera Carlos Grau P érez Luis Lazarov Eduardo Lopez Cristian Oddo Hugo Dibarboure Source Type: research